Updated 06:09 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,790.40 -1.91% CL 84.69 -1.53% BTC 64,606.17 -0.38%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,790 −1.91% BTC $64,606 −0.38% VIX 25.46 +11.13% latest tape · as of 06:09 UTC
The Screen · Financials · Financial Data & Stock Exchanges

Marketwise Inc

MKTW · NASDAQ · USD · Market cap $45M · 451 employees

MarketWise, Inc.

FAIL · Does not pass the screen
20.59 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 06:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price20.59 USD at the 17 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 17 Nov 2026
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $12.90 to $14.83, base estimate $12.90 (screen dated 2026-11-17).

Current read
Accumulation ?
Overvalued · screened 2026-11-17
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price20.59 USD
Fair value12.90
Ethical score30.0/100
Value readOvervaluedas of 17 Nov 2026
Our investment reviews on this name
2026-11-03Read Accumulation19.89+3.5% to today ✓Markdown gives way to Accumulation
2026-10-27Read Markdown19.38+6.2% to today Accumulation gives way to Markdown after an 11% rise in 4 weeks
2026-10-02Read Accumulation17.52+17.5% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-09-05Read Markdown16.90+21.8% to today Markup gives way to Markdown while volume still accumulates

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Marketwise Inc holds its Accumulation at $20.59. Consolidating, no directional conviction, held for 60 days.

As held on the ledger · 2026-11-17
PhaseAccumulation
Quantitative stateConsolidating, no directional conviction, held for 60 days
Price at the screen$20.59
Valuation10.49 trailing · 87.60 forward price to earnings
Values screenFAIL · score 30.0
Beta0.22
The Workings

Five Screens, Shown in Full

Does not pass. Excluded industry: Financial Data & Stock Exchanges

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Excluded industry: Financial Data & Stock Exchanges Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Marketwise does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when MKTW's ethical verdict changes

Today MKTW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 17 Nov 2026: it trades above our $12.90 fair value estimate, none competitive moat.

How a fair value is estimated: discounted cash flow (DCF).

12.90Conservative12.90Base case14.83Growth case 20.59Price

Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. The price runs 59.6% above the base estimate.

The Street's Range
20.00Street low 24.00Street average 24.54Street high 20.59Price

Third-party analyst targets. The average target sits +17% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $12.90, with a range of $12.90 to $14.83, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 87.6x forward earnings, the price already runs ahead of the business. It trades 60% above our $12.90 fair value, so you would be buying at a premium, not a discount. The none moat is real, but quality alone does not make an expensive price cheap.

The fundamentals · plain-English read
Forward P/E87.6xexpensive: the price assumes strong growth ahead
Trailing P/E10.5xreasonably valued
EPS, trailing1.67
EPS, forward0.20
Revenue growth-7.8%revenue is shrinking
Profit margin1.3%barely profitable
Dividend yield5.33%
Beta0.22barely tracks the market's swings
52-week range13.49 - 21.74
MoatNONE
Market cap$45M
Employees451

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

MKTW trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-14 Accumulation $20.46 +2.9% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-11-03 Accumulation · changed $19.89 +2.6% Entry 9

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-10-27 Markdown · changed $19.38 +0.0% Entry 8

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 9% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-10-20 Accumulation $19.38 +10.6% Entry 7

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-10-02 Accumulation · changed $17.52 +3.7% Entry 6

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-09-05 Markdown · changed $16.90 +0.0% Entry 5

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-08-05 Markup $16.90 +0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-07-18 Markup $16.90 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 6%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it none, with a mean price target of $23.

2026-07-03 Markup $16.90 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markup $16.90 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $18.15 -5.2% $0.45 $973 -2.7%
2 months $15.81 +8.9% $0.45 $1,117 +11.7%
3 months $13.69 +25.7% $0.90 $1,323 +32.3%
6 months $15.27 +12.7% $0.90 $1,186 +18.6%
1 year $16.29 +5.6% $1.70 $1,161 +16.1%
2 years $19.13 -10.1% $3.20 $1,067 +6.7%
3 years $35.56 -51.6% $7.00 $681 -31.9%
5 years $146.64 -88.3% $7.20 $167 -83.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever MKTW does next, these words stay.

Marketwise Inc · MKTW · Accumulation · $20.59
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.